[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367399-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-367399-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","advancements-in-circulating-tumor-cell-detection-for-early-cancer-diagnosis-an-integration-of-machine-learning-algorithms-with-microfluidic-technologies","Advancements in Circulating Tumor Cell Detection for Early Cancer Diagnosis: An Integration of Machine Learning Algorithms with Microfluidic Technologies","","Circulating tumor cells (CTCs) serve as key markers of metastasis and enable non-invasive early cancer diagnosis, prognosis, and treatment monitoring, yet their rarity and biological heterogeneity in blood hinder reliable detection. Microfluidic “lab-on-a-chip” platforms support efficient CTC isolation and analysis while reducing sample volume and increasing sensitivity. Size filtration, dielectrophoresis, and immunoaffinity capture improve performance, and combining these devices with machine learning enhances specificity and accuracy. Machine learning automates detection and better identifies rare subpopulations, improving diagnostic reliability and enabling more personalized clinical decisions.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/advancements-in-circulating-tumor-cell-detection-for-early-cancer-diagnosis-an-integration-of-machine-learning-algorithms-with-microfluidic-technologies/367399/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/advancements-in-circulating-tumor-cell-detection-for-early-cancer-diagnosis-an-integration-of-machine-learning-algorithms-with-microfluidic-technologies/367399.png","ImageObject",300,407,{"name":42,"@type":43},"Kyle","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"Why are circulating tumor cells (CTCs) important for early cancer diagnosis?","Question",{"text":63,"@type":64},"CTCs indicate metastasis and provide a non-invasive route for early diagnosis, prognosis, and therapeutic monitoring using liquid biopsy biomarkers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What challenges limit CTC detection in blood?",{"text":68,"@type":64},"CTCs occur at very low concentrations among billions of blood cells and show substantial heterogeneity, making detection difficult.",{"name":70,"@type":61,"acceptedAnswer":71},"How do microfluidic systems improve CTC detection compared with traditional approaches?",{"text":72,"@type":64},"Microfluidic lab-on-a-chip devices reduce sample volume, shorten analysis time, enhance sensitivity, and integrate multiple steps, while techniques like filtration, dielectrophoresis, and immunoaffinity capture improve isolation efficiency.",{"name":74,"@type":61,"acceptedAnswer":75},"What role does machine learning play when integrated with microfluidic technologies?",{"text":76,"@type":64},"Machine learning models automate and refine detection, increasing specificity and accuracy and improving identification of rare, heterogeneous CTC populations to support more personalized treatment decisions.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},367399,1790471345,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Review  \nAdvancements in Circulating Tumor Cell Detection for Early Cancer Diagnosis: An Integration of Machine Learning Algorithms with Microfluidic Technologies  \nLing An 1, Yi Liu 1,* and Yaling Liu 2,3, *  \nReceived: 11 February 2025  \nRevised: 27 March 2025  \nAccepted: 27 March 2025  \nPublished: 29 March 2025  \nCitation: An, L.; Liu, Y.; Liu, Y. Advancements in Circulating Tumor Cell Detection for Early Cancer Diagnosis: An Integration of Machine Learning Algorithms with Microfluidic Technologies. Biosensors 2025, 15, 220. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/bios15040220](10.3390/bios15040220)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 School of Engineering, Dali University, Dali 671003, China; [anling@stu.dali.edu.cn](anling@stu.dali.edu.cn)  \n2 Precision Medicine Translational Research Center, West China Hospital, Sichuan University, Chengdu 610041, China  \n3 Department of Bioengineering, Lehigh University, Bethlehem, PA 18015, USA  \n* Correspondence: [liuyi@dali.edu.cn](liuyi@dali.edu.cn) (Y.L.); [yaling.liu@gmail.com](yaling.liu@gmail.com) (Y.L.)  \nAbstract: Circulating tumor cells (CTCs) are vital indicators of metastasis and provide a non-invasive method for early cancer diagnosis, prognosis, and therapeutic monitoring. However, their low prevalence and heterogeneity in the bloodstream pose significant challenges for detection. Microfluidic systems, or “lab-on-a-chip” devices, have emerged as a revolutionary tool in liquid biopsy, enabling efficient isolation and analysis of CTCs. These systems offer advantages such as reduced sample volume, enhanced sensitivity, and the ability to integrate multiple processes into a single platform. Several microfluidic techniques, including size-based filtration, dielectrophoresis, and immunoaffinity capture, have been developed to enhance CTC detection. The integration of machine learning (ML) with microfluidic systems has further improved the specificity and accuracy of CTC detection, significantly advancing the speed and efficiency of early cancer diagnosis. ML models have enabled more precise analysis of CTCs by automating detection processes and enhancing the ability to identify rare and heterogeneous cell populations. These advancements have already demonstrated their potential in improving diagnostic accuracy and enabling more personalized treatment approaches. In this review, we highlight the latest progress in the integration of microfluidic technologies and ML algorithms, emphasizing how their combination has changed early cancer diagnosis and contributed to significant advancements in this field.  \nKeywords: circulating tumor cells (CTCs); microfluidic systems; machine learning algorithms; early cancer diagnosis  \n1. Introduction  \nCancer remains a leading cause of death worldwide [1] . The global cancer burden is expected to rise to 29 million new cases annually by 2040, a 62% increase from 2018 [2] . Early and precise cancer detection remains a challenge, particularly in metastatic disease, which accounts for over 90% of cancer-related deaths [3] . CTCs, shed from primary tumors into the bloodstream, play a key role in metastasis. CTCs offer critical insights into tumor progression and serve as biomarkers in liquid biopsies for detecting cancers like breast, prostate, and liver cancer [4,5] . However, as shown in Figure 1, the low concentration of CTCs in blood makes their detection challenging, as only a few CTCs are found among billions of blood cells [6–8] . In 1869, Professor Ashworth first identified CTCs in the bloodstream of a cancer patient [9] . Despite the passage of over 150 years since the  \ninitial discovery and characterization of","cbCaieemvDq626Zt","https://ap.wps.com/l/cbCaieemvDq626Zt","pdf",3123308,26,"English","# Introduction\n## Microfluidic technology advantages and applications\n# Abstract\n## Keywords","[{\"question\":\"Why are circulating tumor cells (CTCs) important for early cancer diagnosis?\",\"answer\":\"CTCs indicate metastasis and provide a non-invasive route for early diagnosis, prognosis, and therapeutic monitoring using liquid biopsy biomarkers.\"},{\"question\":\"What challenges limit CTC detection in blood?\",\"answer\":\"CTCs occur at very low concentrations among billions of blood cells and show substantial heterogeneity, making detection difficult.\"},{\"question\":\"How do microfluidic systems improve CTC detection compared with traditional approaches?\",\"answer\":\"Microfluidic lab-on-a-chip devices reduce sample volume, shorten analysis time, enhance sensitivity, and integrate multiple steps, while techniques like filtration, dielectrophoresis, and immunoaffinity capture improve isolation efficiency.\"},{\"question\":\"What role does machine learning play when integrated with microfluidic technologies?\",\"answer\":\"Machine learning models automate and refine detection, increasing specificity and accuracy and improving identification of rare, heterogeneous CTC populations to support more personalized treatment decisions.\"}]","Advancements in Circulating Tumor Cell Detection for Early Cancer Diagnosis: An Integration of Machine Learning Algorithms with Microfluidic Technologies | PDF",1790170627,66,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5fdc0d3cd7bc36c5a5b942db422a092.webp",983,1390,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1595add5d79df23360d7d8041c7cff9.webp",982,1388,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68ab46e6b8a314511df72ae59b8ac1f3.webp",981,1387,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1ec7cbb0fdf76572f9cf333f385c37e.webp",980,1385]